tiprankstipranks
Advertisement
Advertisement

ZNTL Stock Latest News

Zentalis initiated with a Buy at Rodman & Renshaw
The FlyZentalis initiated with a Buy at Rodman & Renshaw
9d ago
ZNTL
Zentalis initiated with an Outperform at Mizuho
PremiumThe Fly
Zentalis initiated with an Outperform at Mizuho
15d ago
ZNTL
Zentalis Shareholders Back Directors, Auditors and Executive Pay
PremiumCompany Announcements
Zentalis Shareholders Back Directors, Auditors and Executive Pay
1M ago
8K
ZNTL
Zentalis assumed with an Outperform at Oppenheimer
PremiumThe Fly
Zentalis assumed with an Outperform at Oppenheimer
2M ago
ZNTL
Zentalis Pharmaceuticals Expands Board, Appoints New Director
PremiumCompany Announcements
Zentalis Pharmaceuticals Expands Board, Appoints New Director
2M ago
8K
ZNTL
Analyst Reiterates Buy on Zentalis as New MUIR Data Bolster Azenosertib Outlook; $10 Price Target Unchanged
PremiumRatingsAnalyst Reiterates Buy on Zentalis as New MUIR Data Bolster Azenosertib Outlook; $10 Price Target Unchanged
2M ago
ZNTL
Zentalis Highlights Promising Azenosertib Data in Ovarian Cancer
Premium
Company Announcements
Zentalis Highlights Promising Azenosertib Data in Ovarian Cancer
2M ago
8K
ZNTL
Zentalis: Buy Rating Reiterated as Azenosertib Strategy Advances; $10 Price Target Maintained on De-Risked Dosing and Late-Stage Catalysts
Premium
Ratings
Zentalis: Buy Rating Reiterated as Azenosertib Strategy Advances; $10 Price Target Maintained on De-Risked Dosing and Late-Stage Catalysts
3M ago
ZNTL
Zentalis reports Q1 EPS (50c), consensus (52c)
PremiumThe Fly
Zentalis reports Q1 EPS (50c), consensus (52c)
3M ago
ZNTL
Zentalis Advances Azenosertib with New Trial Updates
PremiumCompany Announcements
Zentalis Advances Azenosertib with New Trial Updates
3M ago
8K
ZNTL
ZNTL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ZNTL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ZNTL
Zentalis Starts Pivotal Phase 3 ASPENOVA Ovarian Cancer Trial
PremiumCompany Announcements
Zentalis Starts Pivotal Phase 3 ASPENOVA Ovarian Cancer Trial
3M ago
8K
ZNTL
Zentalis Highlights New Azenosertib Data in Breast Cancer
PremiumCompany AnnouncementsZentalis Highlights New Azenosertib Data in Breast Cancer
4M ago
8K
ZNTL
Zentalis to present azenosertib preclinical data in TNBC at AACR meeting
Premium
The Fly
Zentalis to present azenosertib preclinical data in TNBC at AACR meeting
4M ago
ZNTL
Midday Fly By: CoreWeave inks Anthropic, TSMC reports March sales bump
Premium
The Fly
Midday Fly By: CoreWeave inks Anthropic, TSMC reports March sales bump
4M ago
E
MU
Zentalis price target raised to $10 from $6 at Guggenheim
PremiumThe Fly
Zentalis price target raised to $10 from $6 at Guggenheim
4M ago
ZNTL
Zentalis Advances Azenosertib Dose in DENALI Phase 2
PremiumCompany Announcements
Zentalis Advances Azenosertib Dose in DENALI Phase 2
4M ago
8K
ZNTL
Advancing Azenosertib Pipeline and DENALI Readouts Underpin Buy Rating on Zentalis Pharmaceuticals
PremiumRatings
Advancing Azenosertib Pipeline and DENALI Readouts Underpin Buy Rating on Zentalis Pharmaceuticals
4M ago
ZNTL
ZNTL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ZNTL Earnings this Week: How Will it Perform?
5M ago
ZNTL
Zentalis outlines 2026 milestones for azenosertib program
PremiumCompany AnnouncementsZentalis outlines 2026 milestones for azenosertib program
7M ago
8K
ZNTL
Zentalis Pharmaceuticals: Balancing DENALI Momentum and ASPENOVA Visibility Against Pivotal Data and Execution Risk (Hold Rating Maintained)
Premium
Ratings
Zentalis Pharmaceuticals: Balancing DENALI Momentum and ASPENOVA Visibility Against Pivotal Data and Execution Risk (Hold Rating Maintained)
7M ago
ZNTL
Zentalis provides update, key milestones in 2025, expectations for 2026
Premium
The Fly
Zentalis provides update, key milestones in 2025, expectations for 2026
7M ago
ZNTL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >